A new study suggests nitrous oxide may offer a new treatment option for older adults with treatment-resistant depression.

Serial adjunctive ketamine infusions are not more effective than serial midazolam infusions in reducing depressive symptoms ...

A new medication for treatment-resistant depression may help a subset of people who carry a specific genetic marker.

A 2022 study showed that 28.3% of patients receiving ketamine had a billing diagnosis of depression. McLoughlin's group pointed to evidence that suggested ketamine is more effective than esketamine ...

The trial tested repeated ketamine infusions in hospitalized adults with moderate-to-severe depression. Compared to midazolam ...

Researchers from Trinity College, St Patrick’s Mental Health Services, Queen’s University Belfast, Ireland, investigate use ...

Findings from a randomized and blinded clinical trial investigating repeated ketamine infusions for treating depression have revealed no extra benefit for ketamine when added onto standard care for ...

A new clinical trial has found that adding repeated intravenous ketamine infusions to standard care for hospitalized patients ...

The research team analyzed polygenic scores for C-reactive protein, a key marker of inflammation, in 1059 European patients with major depressive disorder who received at least four weeks of ...

At lecture, Helen Mayberg presented findings showing electrical impulses in the brain can induce long-term benefits in patients.

Women who used transdermal hormone therapy (HT) to treat menopausal symptoms experienced lower rates of anxiety and ...